Сообщения

Сообщения за Январь, 2016

Eli Lilly profitiert von Novartis-Zukauf und neuen Produkten

Eli Lilly profitiert von Novartis-Zukauf und neuen Produkten
(dpa-AFX) Der US-Pharmakonzern Eli Lilly hat dank des Zukaufs der Novartis-Sparte für Tiermedizin beim Umsatz im vierten Quartal zugelegt. Die Erlösen kletterten um fünf Prozent auf 5,38 Milliarden US-Dollar, wie das Unternehmen in Indianapolis mitteilte. Ohne Währungseffekte durch den starken Dolla...

from bionity.com News | Ein Übersichtsbeitrag über Goldankauf in Berlin, Germany.

Johnson & Johnson (JNJ) Shares Bought by Armstrong Henry H Associates Inc.

Johnson & Johnson (JNJ) Shares Bought by Armstrong Henry H Associates Inc.
Armstrong Henry H Associates Inc. raised its position in Johnson & Johnson by 1.1% during the fourth quarter, according to its most recent 13F filing with the Securities and Exchange Commission . The firm owned 488,609 shares of the company's stock after buying an additional 5,222 shares during the period.

from Biotech News

Atlas Brown Inc. Has $457,000 Position in Merck & Co., Inc.

Atlas Brown Inc. Has $457,000 Position in Merck & Co., Inc.
Atlas Brown Inc. reduced its position in shares of Merck & Co., Inc. by 5.5% during the fourth quarter, according to its most recent disclosure with the Securities and Exchange Commission. The fund owned 9,074 shares of the company's stock after selling 528 shares during the period.

from Biotech News

Six people being tested for Zika virus in Bexar County

Six people being tested for Zika virus in Bexar County
This 2006 photo provided by the Centers for Disease Control and Prevention shows a female Aedes aegypti mosquito in the process of acquiring a blood meal from a human host. On Friday, Jan. 15, 2016, U.S. health officials are telling pregnant women to avoid travel to Latin America and Caribbean countries with outbreaks of a tropical illness linked to birth defects.

from Biotech News

26,193 Shares in Biogen Inc (BIIB) Acquired by Accident Compensation Corp

26,193 Shares in Biogen Inc (BIIB) Acquired by Accident Compensation Corp
Accident Compensation Corp bought a new stake in shares of Biogen Inc during the fourth quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission. The firm bought 26,193 shares of the biotechnology company's stock, valued at approximately $8,024,000.

from Biotech News

Among high risk kids, both boys and girls are victims of dating violence

Among high risk kids, both boys and girls are victims of dating violence
For kids and teens exposed to violence at home or in the community, boys are just as likely to be seriously hurt by a romantic partner, although the risk changes with age, according to a new study. "Most samples are not specifically high risk populations where youth are previously exposed to violence," said lead author Dennis E. Reidy of the Division of Violence Prevention at the Centers for Disease Control and Prevention in Atlanta.

from Biotech News

Ga. Police Chase Ends In Deaths, Drug Trafficking Charges

Ga. Police Chase Ends In Deaths, Drug Trafficking Charges
A father and son from Mosheim face multiple charges following a traffic crash Thursday night in Gwinnett County, Ga., that killed the occupants of the other vehicle. Larry Edward Thomas, 47, of 580 Bewley Road, was driving a Ford Crown Victoria sedan that collided with a Mercedes in Gwinnett County as it was being pursued by a Johns Creek Police Department officer from neighboring Fulton County, according to a news release from the Gwinett County Police Department.

from Biotech News

What To Buy In This Biotech Sell-Off

What To Buy In This Biotech Sell-Off
I wrote this article myself, and it expresses my own opinions. I am not receiving compensation for it .

from Biotech News

State confirms 3 SC residents tested for Zika virus

State confirms 3 SC residents tested for Zika virus
Health officials say three people in South Carolina are being tested for the Zika virus, but no cases of the disease have been confirmed yet. Department official Dr. Teresa Foo tells local media that the chances of getting Zika virus in South Carolina are minuscule.

from Biotech News

Gilead: Detailed Insight And Interpretation Behind The Headlines: Should You Be Scared?

Gilead: Detailed Insight And Interpretation Behind The Headlines: Should You Be Scared?
I wrote this article myself, and it expresses my own opinions. I am not receiving compensation for it .

from Biotech News

Hillary, Don't Attack Valeant, Attack Lawmakers

Hillary, Don't Attack Valeant, Attack Lawmakers
I wrote this article myself, and it expresses my own opinions. I am not receiving compensation for it .

from Biotech News

Danbury-based firm lays off half its staffers

Danbury-based firm lays off half its staffers
Danbury-based pharmaceutical developer Biodel has laid off 15 people, more than half of its workforce, after a crumbled partnership forced it to suspend a drug trial and evaluate options including a sale or a reverse merger, in which another company would acquire Biodel for its Nasdaq listing and cash reserves. It would amount to an ignominious end for Biodel, created in 2003 by onetime MannKind executive Dr. Solomon Steiner and others who set out initially to develop VIAject, an insulin treatment for diabetics designed to be absorbed into the blood faster than alternatives at the time, with a later version of the technology called Linjeta.

from Biotech News

More airlines offer Zika refunds to pregnant women

More airlines offer Zika refunds to pregnant women
Doctor Angela Rocha shows brain scans of a baby born with microcephaly at the Oswaldo Cruz Hospital in Recife, Brazil, Thursday, Jan. 28, 2016. Brazilian officials still say they believe there's a sharp increase in cases of microcephaly and strongly suspect the Zika virus, which first appeared in the country last year, is to blame.

from Biotech News

FDA OKs Merck hepatitis C drug, adding to patient choices

FDA OKs Merck hepatitis C drug, adding to patient choices
Patients with hepatitis C have yet another advanced treatment option, as the Food and Drug Administration on Thursday approved a new once-a-day pill developed by drugmaker Merck. The FDA said Merck can begin marketing Zepatier for patients with two of the subtypes the liver-destroying virus, types 1 and 4. The combination pill includes the medications elbasvir and grazoprevir, which attack the virus in two different ways.

from Biotech News

Amgen trounces Street views with 39 pct. jump in 4Q profit

Amgen trounces Street views with 39 pct. jump in 4Q profit
This Nov. 9, 2014, file photo, shows signage outside the Amgen headquarters in Thousand Oaks, Calif. Amgen Inc. reports financial results on Thursday, Jan. 28, 2016.

from Biotech News

Late run sees ASX finish on a high

Late run sees ASX finish on a high
The Australian share market has raced home on a high note after enduring a fitful session of ups and downs. A strong late run from the big four banks helped steer the bourse out of the red after it was weaker for most of trade.

from Biotech News

Records: Site had proper procedures before listeria outbreak

Records: Site had proper procedures before listeria outbreak
A newspaper says inspection records show that a southwestern Ohio facility that produced packaged salads linked to a listeria outbreak had proper procedures in place in recent years to prevent illness. The Centers for Disease Control and Prevention said last week it linked the six-state outbreak to Dole salads this month after Ohio agriculture officials found listeria in a bag bought at a retail location.

from Biotech News

Roche blickt optimistisch in die Zukunft

Roche blickt optimistisch in die Zukunft
(dpa-AFX) Der Schweizer Pharmakonzern Roche sieht dank aussichtsreicher Medikamentenentwicklungen vorsichtig optimistisch in die Zukunft. 2016 dürfte es moderate Umsatzsteigerungen geben, der betriebliche Kerngewinn soll etwas stärker wachsen. Währungseffekte klammert das Unternehmen jedoch aus. Der...

from bionity.com News | Ein Übersichtsbeitrag über Goldankauf in Berlin, Germany.

Obama creates new federal task force on cancer

Obama creates new federal task force on cancer
Obama signed a presidential memo Thursday establishing the White House Cancer Moonshot Task Force. The memo says the goal is to double the rate of progress on treatment and prevention.

from Biotech News

Stamford audio giant drops after bell

Stamford audio giant drops after bell
On January 25, 2016, Harman International Industries held the official opening of its new North American automotive headquarters in Novi, Mich., with the company employing 1,000 people inside the 190,000-square-foot center in Haggerty Corridor Corporate Park. On January 25, 2016, Harman International Industries held the official opening of its new North American automotive headquarters in Novi, Mich., with the company employing 1,000 people inside the ... more Shares of Harman International Industries fell 6 percent in early trading Thursdsay, after the Stamford-based company reported a drop in earnings for its second fiscal quarter compared to a year earlier.

from Biotech News

Bristol-Myers posts 4Q loss, but beats views as sales rise

Bristol-Myers posts 4Q loss, but beats views as sales rise
Bristol-Myers Squibb Co. swung from a tiny profit to a loss in the fourth quarter as it fought multiple headwinds, but it still beat Wall Street expectations.

from Biotech News

IBM: Will Big Data Analytics + Big Pharma = Big Profits?

IBM: Will Big Data Analytics + Big Pharma = Big Profits?
I/we have no positions in any stocks mentioned, and no plans to initiate any positions within the next 72 hours. What if everyone's health history was recorded and analyzed? What could be done with this information to improve treatment regimens or develop new medicines? A couple of recent pairings are working to answer these questions.

from Biotech News

Regeneron wants to build a second East Greenbush campus

Regeneron wants to build a second East Greenbush campus
Regeneron submitted this site plan for a second campus it wants to build neat Exit 9 on Interstate 90. The campus would have 1,500 parking spaces when completed. It would have office, lab, warehouse and manufacturing space.

from Biotech News

3 Must Own Biotech Stocks For February

3 Must Own Biotech Stocks For February
The biotech sector has been in an official bear market for some time and is down some 30% since its recent peak in mid-summer. Bargains abound for patient long-term investors.

from Biotech News

Massachusetts is investigating high cost of hepatitis C drug

Massachusetts is investigating high cost of hepatitis C drug
The Massachusetts attorney general's office is investigating whether the makers of a breakthrough treatment for hepatitis C are violating state law by pricing the drug too high. Attorney General Maura Healey on Wednesday released a letter sent to the chief executive of California-based Gilead Sciences Inc. In it, Healey said her office was examining whether the pricing constituted an unfair trade practice.

from Biotech News

Novartis geht für 2016 von starker Generika-Konkurrenz aus

Novartis geht für 2016 von starker Generika-Konkurrenz aus
(dpa-AFX) Der Schweizer Pharmakonzern Novartis geht für das laufende Jahr erneut von einer starken Konkurrenz durch Generika aus. Auch die Dollar-Stärke dürfte den Konzern weiter belasten. Wachstum in allen Sparten soll die Belastungen aber ausgleichen, so dass sich die Schweizer für 2016 Erlöse und...

from bionity.com News | Ein Übersichtsbeitrag über Goldankauf in Berlin, Germany.

Biogen 4Q profit falls on costs, but tops forecasts

Biogen 4Q profit falls on costs, but tops forecasts
In this Feb. 15, 2006, file photo, two women walk by Biogen Idec corporate headquarters in Cambridge, Mass. Biogen reports financial earnings Wednesday, Jan. 27, 2016.

from Biotech News

Things to know about the mosquito villain in Zika outbreaks

Things to know about the mosquito villain in Zika outbreaks
This 2006 photo provided by the Centers for Disease Control and Prevention shows a female Aedes aegypti mosquito in the process of acquiring a blood meal from a human host. Scientists believe the species originated in Africa, but came to the Americas on slave ships.

from Biotech News

Supergroup PLC's (SGP) "Hold" Rating Reaffirmed at Numis Securities Ltd

Supergroup PLC's (SGP) "Hold" Rating Reaffirmed at Numis Securities Ltd
's stock had its "hold" rating reissued by analysts at Numis Securities Ltd in a research note issued to investors on Wednesday, AnalystRatings.Net reports. They currently have a GBX 1,400 target price on the stock.

from Biotech News

United, American offering refunds for travel to Zika areas

United, American offering refunds for travel to Zika areas
American Airlines says it will give refunds to pregnant women who were planning to travel to parts of Central America. The U.S. Centers for Disease Control and Prevention have warned pregnant women to take precautions against mosquito bites when traveling to areas in Latin America and the Caribbean where there have been Zika outbreaks.

from Biotech News

The Latest: Virginia resident tests positive for Zika virus

The Latest: Virginia resident tests positive for Zika virus
The latest on the fight against the Zika virus that health officials suspect is linked to a wave of birth defects in Brazil. : Health officials say a Virginia resident who travelled outside the United States has tested positive for Zika, a mosquito-transmitted virus.

from Biotech News

ASHP Publishes Guide for Treating Obese Patients

ASHP Publishes Guide for Treating Obese Patients
A new publication from ASHP will help clinicians determine optimal medication doses for obese patients. Demystifying Drug Dosing in Obese Patients is the first text focused on dosing critical and narrow therapeutic index drugs in obese pediatric and adult patients. The publication provides an overview of dosing medications in obese patients and summarizes the available literature for dosing of antimicrobial agents, anticoagulant and antiplatelet drugs, antiepileptic, antineoplastic, and analgesic medications. The reference includes insight and recommendations from nationally recognized experts, including sample calculations and equations to help clinicians apply the literature to individual patients. “The sharp growth in obesity rates in the United States heightens the need for clear, evidence-based guidance,” says Brandon R. Shank, Pharm.D., BCOP, a co-editor of the text. “It is essential that clinicians have a thorough understanding o…

The Latest: US starts research into possible Zika vaccine

The Latest: US starts research into possible Zika vaccine
The latest on the fight against the Zika virus that health officials suspect is linked to a wave of birth defects in Brazil. : The U.S. government is beginning research into a possible vaccine for the mosquito-borne Zika virus that is suspected of causing an unusual birth defect as it spreads in Latin America.

from Biotech News

Oil fuels 'schizophrenic' Wall Street rebound

Oil fuels 'schizophrenic' Wall Street rebound
Wall Street rebounded over 1 percent on Tuesday, driven by a surge in oil prices and strong quarterly results from 3M, Johnson & Johnson and Procter & Gamble. All 10 major S&P sectors ended higher, led by a 3.78-percent rise in the energy sector.

from Biotech News

Morphosys erhält Meilensteinzahlung von Bayer

Morphosys erhält Meilensteinzahlung von Bayer
(dpa-AFX) Das Biotech-Unternehmen Morphosys hat für den Start einer Phase-2-Studie von dem Chemie- und Pharmakonzern Bayer eine Meilensteinzahlung erhalten. Ziel der Studie sei es, die Zulassung des Wirkstoffs Anetumab Ravtansine zu unterstützen, teilte Morphosys am Dienstag mit. Bei dem Wirkstoff h...

from bionity.com News | Ein Übersichtsbeitrag über Goldankauf in Berlin, Germany.

Big U.S. biotech profit reports could boost industry's swooning shares

Big U.S. biotech profit reports could boost industry's swooning shares
Biotech's biggest companies could help restore investor confidence in the beaten-up industry as they report quarterly results starting this week. Valuations suggest biotech shares could be closing in on a bottom, and some analysts said strong results could clear the way for potential buyers.

from Biotech News

Open-source Laser Fabrication Lowers Costs for Cancer Research

Open-source Laser Fabrication Lowers Costs for Cancer Research
In a move that slashes 90 percent of the cost of mass-producing metastatic microtumors and therapeutic microtissues for screening and research, Rice University bioengineers have adapted techniques from the "maker" movement to reprogram a commercial laser cutter to etch up to 50,000 tiny "microwells" per hour into sheets of silicone. The fabrication technique, which was developed with open-source software and hardware, is described in a new study published in the journal RSC Advances .

from Biotech News

Johnson & Johnson beats 4Q profit forecasts

Johnson & Johnson beats 4Q profit forecasts
In this Monday, July 16, 2012, file photo, Johnson & Johnson products are displayed in Orlando, Fla.

from Biotech News

Biotech Weekly: The NASDAQ Sub $10 Million Market Cap Club

Biotech Weekly: The NASDAQ Sub $10 Million Market Cap Club
Reasons to review the NASDAQ sub $10 million market cap list include the value of a NASDAQ listing, significant remaining assets, overly negative sentiment, and ignored upside scenarios. Current sub $10 million market cap NASDAQ biotechs include Cellectar Biosciences, Nanosphere, Lpath, Signal Genetics, Venaxis, TetraLogic Pharmaceuticals, Eleven Biotherapeutics, and GenVec.

from Biotech News

Biotech Deserves A Piece Of Every Dividend Growth Portfolio

Biotech Deserves A Piece Of Every Dividend Growth Portfolio
Taking into account their projected EPS growth rates and potential for dividend growth, both companies, but in particular Gilead Sciences, are attractively valued relative to the market. Amgen became a pioneer in the biotech world when it became the first large biotech stock to begin paying a regular dividend in 2011.

from Biotech News

Reasons to Expect Strong Bristol-Myers Earnings

Reasons to Expect Strong Bristol-Myers Earnings
Recent market volatility and global pressures have tempered investors' expectations for a strong earnings season, but not all companies will do poorly. Although Bristol-Myers Squibb shares -- down some 7% year to date -- is not off to a good start in 2016, the multinational drug giant belongs on any short list of companies poised to beat Wall Street's earnings estimates.

from Biotech News

Women advised to avoid pregnancy as Zika virus spreads

Women advised to avoid pregnancy as Zika virus spreads
Women advised to avoid pregnancy as Zika virus spreads In El Salvador, authorities have asked women not to get pregnant until 2018. Check out this story on WFAA.com: http://usat.ly/1RJho92 In the past year, Zika has spread from Africa and Asia through the Americas.

from Biotech News

Johnson & Johnson Earnings May Be Scrutinized For Deal Buzz, Product Snags

Johnson & Johnson Earnings May Be Scrutinized For Deal Buzz, Product Snags
On average, analysts reporting to Thomson Reuters are looking for JNJ earnings of $1.42 a share on top-line sales of $17.9 billion. Short-term option traders are looking for the earnings news to potentially generate a 2.5% move on the stock in either direction.

from Biotech News

European organic and biotech industries clash over plant breeding techniques

European organic and biotech industries clash over plant breeding techniques
"To me IFOAM's reaction is a bit of a Pavlov's dog reflex. If you dig a bit deeper you see that people look at these techniques in a differentiated way," said Garlich Von Essen of the European Seed Association.

from Biotech News

Democratic senator blocks Obama's pick to head FDA

Democratic senator blocks Obama's pick to head FDA
Massachusetts Sen. Edward Markey says in a statement that he's put a hold on Dr. Robert Califf's nomination. The Centers for Disease Control and Prevention says deaths linked to misuse and abuse of prescription painkillers climbed to 19,000 last year, the highest on record.

from Biotech News

Gilead Closes Galapagos Deal- Opens Up Massive Market Opportunity

Gilead Closes Galapagos Deal- Opens Up Massive Market Opportunity
I wrote this article myself, and it expresses my own opinions. I am not receiving compensation for it .

from Biotech News

Novavax Announces Proposed Offering of $200 Million of Convertible Senior Notes Due 2023

Novavax Announces Proposed Offering of $200 Million of Convertible Senior Notes Due 2023
Novavax, Inc. , a clinical-stage vaccine company focused on the discovery, development and commercialization of recombinant nanoparticle vaccines and adjuvants, today announced that it intends to offer, subject to market and other conditions, $200 million aggregate principal amount of convertible senior unsecured notes that will mature on February 1, 2023 . The Notes will be offered and sold only to qualified institutional buyers pursuant to Rule 144A under the Securities Act of 1933, as amended.

from Biotech News

GSK, Astra, J&J link with universities in new drug research fund

GSK, Astra, J&J link with universities in new drug research fund
GlaxoSmithKline, AstraZeneca and Johnson & Johnson have joined with three leading British universities to create a new 40 million pounds fund backing early drug research. The Apollo Therapeutics Fund, which aims to improve the speed and potential of university research being translated into new medicines, is a further example of a trend by Big Pharma to tap into academic science in the hunt for treatments.

from Biotech News

QLT Inc. (QLTI) Earns Hold Rating from Zacks Investment Research

QLT Inc. (QLTI) Earns Hold Rating from Zacks Investment Research
's stock had its "hold" rating reiterated by Zacks Investment Research in a report issued on Sunday, AnalystRatings.Net reports. They currently have a $3.00 target price on the stock.

from Biotech News

Opexa Therapeutics Inc (OPXA) Upgraded to "Buy" by Zacks Investment Research

Opexa Therapeutics Inc (OPXA) Upgraded to "Buy" by Zacks Investment Research
The firm presently has a $2.00 price target on the biopharmaceutical company's stock. Zacks Investment Research 's target price indicates a potential upside of 4.04% from the stock's current price.

from Biotech News

LDC und Roche wollen gemeinsam innovative Wirkstoffprojekte vorantreiben

LDC und Roche wollen gemeinsam innovative Wirkstoffprojekte vorantreiben
Die Lead Discovery Center GmbH (LDC) und Roche werden kooperieren, um innovative therapeutische Ansätze zu identifizieren und gemeinsam zu erforschen. Der Fokus liegt auf Krankheitsgebieten mit einem dringenden medizinischem Bedarf. Projektideen können sowohl von akademischen Partnern des LDC stamme...

from bionity.com News | Ein Übersichtsbeitrag über Goldankauf in Berlin, Germany.

USC Eye Study Finds Near-Sightedness Growing

USC Eye Study Finds Near-Sightedness Growing
The largest study of childhood eye diseases undertaken in the U.S. confirms that the incidence of childhood myopia among American children has more than doubled over the last 50 years, USC and the National Institutes of Health announced Wednesday. The findings from the Multi-Ethnic Pediatric Eye Disease Study echo research among adults and children in Asia, where 90 percent or more of the population have been diagnosed with near-sightedness, up from 10 to 20 percent 60 years ago, according to Dr. Rohit Varma, and director of the USC Eye Institute at Keck Medicine at USC.

from Biotech News

ETF Update: 4 New Launches And 2 Closures

ETF Update: 4 New Launches And 2 Closures
I/we have no positions in any stocks mentioned, and no plans to initiate any positions within the next 72 hours. Every week, Seeking Alpha aggregates ETF updates in an effort to alert readers and contributors to changes in the market.

from Biotech News

Flint hospital suspected river, Legionnaires' outbreak link

Flint hospital suspected river, Legionnaires' outbreak link
Conor Ralph/The Flint Journal-MLive.com via AP Flint resident Grant Porter, 5, watches as his mother Ardis Porter, 26, has her blood drawn for lead testing at the Flint Masonic Temple on Saturday in Flint, Michigan. Porter said she was having her and her son tested because she's pregnant and he's young.

from Biotech News

Lenox Wealth Advisors Divests From Position in SPDR S&P Biotech

Lenox Wealth Advisors Divests From Position in SPDR S&P Biotech
Lenox Wealth Advisors sold its position in shares of SPDR S&P Biotech during the fourth quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission . The firm previously had a 735 share position in the company, valued at approximately $145,831.

from Biotech News

Medical Marijuana Biotech Brands - Potbotics is a Biotech Startup...

Medical Marijuana Biotech Brands - Potbotics is a Biotech Startup...
Potbotics is a scientific cannabis startup that brings biotechnology into dispensaries everywhere. With what the brand describes as "diverse technology," Potbotics incorporates robotics, artificial intelligence, cannabis research and DNA analysis.

from Biotech News

Mitchell Sinkler & Starr Continues to Hold Position in Novartis AG

Mitchell Sinkler & Starr Continues to Hold Position in Novartis AG
Mitchell Sinkler & Starr held its stake in shares of Novartis AG during the fourth quarter, according to its most recent filing with the Securities and Exchange Commission. The hedge fund owned 3,596 shares of the company's stock at the end of the fourth quarter.

from Biotech News

CBC retracts anti-supplements story based on faulty tests

CBC retracts anti-supplements story based on faulty tests
The Canadian Broadcasting Corporation has retracted a report it aired recently alleging spiking and missing ingredients in supplements because it was based on faulty test results. The report, aired on the CBC show Marketplace, alleged that Emergen-C, made by Pfizer, and and two protein powders, GNC Lean Shake 25 and Cytosport Muscle Milk, did not meet label claims.

from Biotech News

McKesson Co. (MCK) Position Held by Private Asset Management

McKesson Co. (MCK) Position Held by Private Asset Management
Private Asset Management held its position in McKesson Co. during the fourth quarter, according to its most recent filing with the Securities and Exchange Commission .

from Biotech News

Amgen announces approval of cholesterol-lowering medication Repatha (evolocumab) Injection in Japan

Amgen announces approval of cholesterol-lowering medication Repatha (evolocumab) Injection in Japan
Amgen today announced that the Japanese Ministry of Health, Labour and Welfare has approved the cholesterol-lowering medication Repatha Injection, the first proprotein convertase subtilisin/kexin type 9 inhibitor to be approved in Japan. Repatha is a human monoclonal antibody that inhibits PCSK9, a protein that reduces the liver's ability to remove low-density lipoprotein cholesterol , or "bad" cholesterol, from the blood.

from Biotech News

Galena Biopharma Inc (GALE) Receives "Outperform" Rating from Oppenheimer

Galena Biopharma Inc (GALE) Receives "Outperform" Rating from Oppenheimer
's stock had its "outperform" rating restated by equities research analysts at Oppenheimer in a research report issued to clients and investors on Friday, MarketBeat reports. They currently have a $4.00 price objective on the biotechnology company's stock.

from Biotech News

Is your skin scrub enviro-friendly? More companies agree not to use microbeads

Is your skin scrub enviro-friendly? More companies agree not to use microbeads
Eleven major companies have now agreed to phase out microbeads from face scrub cosmetic products since Fairfax Media first reported on the campaign by environmental activist Jon Dee more than a year ago. Mr Dee said that two more major companies, Johnson & Johnson and Metcash, owners of IGA supermarkets, had this week agreed to support the scheme.

from Biotech News

Health officials probe tie between Zika, paralyzing syndrome

Health officials probe tie between Zika, paralyzing syndrome
Health officials say they're trying to determine if an unusual jump in cases of the rare Guillain-Barre Syndrome is related to the spread of the mosquito-borne Zika virus in El Salvador. Fears the illness might cause birth defects already has led authorities in the Central American nation to warn women against becoming pregnant.

from Biotech News

1 dead in listeria outbreak linked to packaged lettuce

1 dead in listeria outbreak linked to packaged lettuce
Packaged salads produced at a Dole facility in Ohio are linked to one death in Michigan, the Centers for Disease Control and Prevention said Friday. The CDC said 12 people in six states have been hospitalized in the outbreak since July after eating salads sold under the names Dole, Fresh Selections, Simple Truth, Marketside, The Little Salad Bar and President's Choice.

from Biotech News

Astellas Pharma $8.50 Tender Offer For Ocata Therapeutics Offer Fails Again

Astellas Pharma $8.50 Tender Offer For Ocata Therapeutics Offer Fails Again
The ongoing battle for control of Ocata Therapeutics inched closer to completion today as an SEC filing reveals that 47% of outstanding shares have been tendered in response to the November 19, 2015 tender offer by Japan based Astellas Pharma to acquire the stem cell therapeutics company. This is the second extended tender deadline that has failed to achieve the required 50.1% shares despite an aggressive campaign by Ocata management to convince shareholders that the $360,000,000 tender offer is in the best interest of shareholders.

from Biotech News

Meningitis B vaccine shortage halts new private jabs

Meningitis B vaccine shortage halts new private jabs
Parents hoping to have their children vaccinated privately against meningitis B have been told there is a shortage of vaccine. But private clinics in the UK have been advising parents that they cannot start any new courses of the vaccine.

from Biotech News

MannKind Launches New Direction For Afrezza

MannKind Launches New Direction For Afrezza
MannKind Corporation's long-term CFO and newly chosen CEO, Matt Pfeffer, recently advanced a new blueprint at the J.P. Morgan Healthcare Conference, held two weeks ago, for the company's direction now that MannKind's partnership with Sanofi will be coming to an end.

from Biotech News

Zika virus likely to spread to southern United States

Zika virus likely to spread to southern United States
By Karen Pallarito HealthDay Reporter THURSDAY, Jan. 21, 2016 -- As cases of the mosquito-borne Zika virus are spreading across central and South America and the Caribbean, experts say it's only a matter of time before the disease, which has been linked to an alarming increase in birth defects in Brazil, is transmitted within the United States. "It's not if, it's when," said Mustapha Debboun, director of the mosquito control division at Harris County Public Health and Environmental Services in Houston.

from Biotech News

UPDATE 1-J&J stops trials of drug similar to one linked to brain death in France

UPDATE 1-J&J stops trials of drug similar to one linked to brain death in France
Jan 21 Johnson & Johnson has suspended international trials of a drug in the same class as an experimental drug made by Portuguese pharmaceutical company Bial, whose tests in France left one person brain dead and five others hospitalized. A spokesman for Johnson & Johnson said in an emailed statement that it voluntarily suspended two mid-stage trials and had not received reports of serious adverse events in its studies of patients with social anxiety disorder and major depressive disorder with anxious distress.

from Biotech News

An Increased Emphasis on "Proportional Discovery"

An Increased Emphasis on "Proportional Discovery"
Magistrate Judge Grewal has denied a motion to compel discovery because the requests were "disproportionate," alluding to the requirement in newly amended Rule 26 , F.R.Civ.P., that the discovery sought should be "proportional to the needs of the case." Gilead Sciences, Inc. v.

from Biotech News

Goldman Plans To Dominate M&A In 2016

Goldman Plans To Dominate M&A In 2016
Goldman Sachs dominated deal advisory for this strong M&A market last year and expects to do so again this year. In the fourth quarter, investment banking made up over 20% of the bank's revenue, up from 15% a few years before.

from Biotech News

Roche erhält für Leukämie-Medikament Breakthrough Therapy-Status

Roche erhält für Leukämie-Medikament Breakthrough Therapy-Status
(dpa-AFX) Roche hat von der US-Gesundheitsbehörde FDA für das Medikament Venetoclax in Kombination mit MabThera/Rituxan (Rituximab) von der US-Gesundheitsbehörde FDA den "Breakthrough Therapy"-Status erhalten. Das Leukämie-Medikament entwickelt die Roche-Tochter Genentech zusammen mit Abbvie. Das Mi...

from bionity.com News | Ein Übersichtsbeitrag über Goldankauf in Berlin, Germany.

UPDATE 1-Five charged in U.S. with stealing secrets from GlaxoSmithKline

UPDATE 1-Five charged in U.S. with stealing secrets from GlaxoSmithKline
The indictments include charges of conspiracy to steal trade secrets, conspiracy to commit wire fraud, conspiracy to commit money laundering, theft of trade secrets, and wire fraud. The stolen information on drugs for cancer and other serious diseases "potentially could be sold for millions of dollars to rival pharmaceutical companies and it would also be useful information for a start-up pharmaceutical company," the complaint said.

from Biotech News

Five charged in US with trying to steal from pharma giant

Five charged in US with trying to steal from pharma giant
A US judge has charged five people with trying to steal trade secrets from the British pharmaceutical group GlaxoSmithKline . The indictment says the five suspects tried to steal secrets from the company's work in biopharmaceuticals, mainly in products to treat cancer and other grave diseases.

from Biotech News

The Latest: Austria calls for EU asylum reform

The Latest: Austria calls for EU asylum reform
Bracing cold temperatures hundreds of migrants continue to arrive daily into Serbia in order to register a... Schools would have more flexibility to serve refined grains and salty foods to the nation's school children under legislation a Senate panel is considering. The Supreme Court has rejected an appeal from the manufacturer of Children's Motrin over a $63 million judgment awarded to a family whose daughter developed a life-threatening disease after taking the medicine.

from Biotech News

5 charged in alleged scheme to steal drug secrets

5 charged in alleged scheme to steal drug secrets
Five people have been accused in federal court of taking part in an alleged scheme to steal biopharmaceutical trade secrets from GlaxoSmithKline and sell them to competitors in China. Charges in the indictment include conspiracy to steal trade secrets and conspiracy to commit wire fraud and money laundering.

from Biotech News

More

More
Two types of children's cough syrup sold at stores with outlets in Central Texas are being recalled after dosing cups with incorrect markings were included in the packaging. Experts say that could lead to accidental overdoses.

from Biotech News

Spreading Zika virus a new economic strain for Latin America

Spreading Zika virus a new economic strain for Latin America
A U.S. warning that pregnant women should avoid Latin American countries where a mosquito-borne virus is multiplying couldn't have come at a worse time for a region that's counting on tourism to give it a boost at a time of economic crises. The alert issued Friday by the Atlanta-based Centers for Disease Control and Prevention covers 14 countries and territories in the Americas where the Zika virus has been detected.

from Biotech News

Namenswechsel: Cytos Biotechnology wird zu Kuros Biosciences

Namenswechsel: Cytos Biotechnology wird zu Kuros Biosciences
Kuros Biosciences AG (vormals Cytos Biotechnology AG) hat den Vollzug der Akquisition von Kuros Biosurgery Holding AG sowie den Namenswechsel zu Kuros Biosciences AG bekannt gegeben. Ab dem 20. Januar 2016 sind sämtliche 508.432.244 Kuros Biosciences AG Aktien börsenkotiert unter dem Ticker Symbol K...

from bionity.com News | Ein Übersichtsbeitrag über Goldankauf in Berlin, Germany.

Johnson & Johnson baut Stellen ab

Johnson & Johnson baut Stellen ab
(dpa-AFX) Der US-Pharma- und Konsumgüterkonzern Johnson & Johnson (J&J) setzt in seinem Profi-Medizintechnik-Geschäft den Rotstift an. Rund 4 bis 6 Prozent der Mitarbeiter weltweit in diesem Bereich sollen dabei innerhalb von zwei Jahren ihren Posten verlieren, teilte der Konzern am Dienstag mit. So...

from bionity.com News | Ein Übersichtsbeitrag über Goldankauf in Berlin, Germany.

Why You Still Have to Dress for Success

Why You Still Have to Dress for Success
Even in this era of jeans and T-shirts in the office, I still get dressed up -- for work, for fun and even for a weekend night at home. My very first job in high school was at JCPenney, then out of college it was Nestle, and then out of graduate school it was Johnson & Johnson -- with a coat and tie the entire time.

from Biotech News

What You Can Achieve With Dividend Investing, A Johnson & Johnson Case Study

What You Can Achieve With Dividend Investing, A Johnson & Johnson Case Study
In this article, I explore why new dividend growth investors should focus on the long haul instead of short-term noise. Dividend growth investing is a long-term strategy but the poor performance of the market is creating doubt in the mind of new investors.

from Biotech News

Global Vaccine promises $5 million to develop Ebola vaccine

Global Vaccine promises $5 million to develop Ebola vaccine
The global vaccine alliance GAVI says it will donate $5 million toward developing the leading Ebola vaccine, hoping that it will be approved by a regulator by the end of 2017. If the vaccine is given the green light, GAVI says it will then create a stockpile to help stamp out future outbreaks of the lethal disease.

from Biotech News

Insider Buying: Neptune Technologies & Bioressources Inc (NTB)...

Insider Buying: Neptune Technologies & Bioressources Inc (NTB)...
Neptune Technologies & Bioressources Inc insider Mario Paradis acquired 10,000 shares of the firm's stock in a transaction that occurred on Monday, January 18th. The stock was bought at an average price of C$1.50 per share, with a total value of C$15,000.00.

from Biotech News

CDC: Ask pregnant women about trips to Zika outbreak areas

CDC: Ask pregnant women about trips to Zika outbreak areas
This 2006 file photo provided by the Centers for Disease Control and Prevention shows a female Aedes aegypti mosquito in the process of acquiring a blood meal from a human host. The The Centers for Disease Control and Prevention on Tuesday, Jan. 19, 2016, announced new guidance for doctors whose pregnant patients may have traveled to regions with a tropical illness linked to birth defects.

from Biotech News

Johnson & Johnson to cut about 3,000 jobs in medical devices

Johnson & Johnson to cut about 3,000 jobs in medical devices
Johnson & Johnson said Tuesday that it plans to cut about 3,000 jobs over the next two years as the health care conglomerate works to restructure its medical devices business. The New Brunswick, New Jersey, company said that amounts to more than 2 percent of its global workforce of around 127,000 people and 4 percent to 6 percent of its employee total in medical devices.

from Biotech News

FBI: Violent crime rose in first 6 months of 2015 over 2014

FBI: Violent crime rose in first 6 months of 2015 over 2014
Preliminary data released by the FBI show violent crime rose across the country in the first six months of 2015 compared to the same period the year before. Preliminary data released by the FBI show violent crime rose across the country in the first six months of 2015 compared to the same period the year before.

from Biotech News

Merck beruft neue Mitglieder der Geschäftsleitung

Изображение
Merck beruft neue Mitglieder der Geschäftsleitung

Der Gesellschafterrat der E. Merck KG hat zwei neue Mitglieder der Geschäftsleitung der Merck KGaA bestellt: Udit Batra (45), Leiter des Unternehmensbereichs Life Science, sowie Walter Galinat (59), Leiter des Unternehmensbereichs Performance Materials, werden zum 30. April 2016 unter Beibehaltung i...

from bionity.com News | Ein Übersichtsbeitrag über Goldankauf in Berlin, Germany.

High court rejects appeal over $63M judgment in Motrin case

High court rejects appeal over $63M judgment in Motrin case
The Supreme Court has rejected an appeal from the manufacturer of Children's Motrin over a $63 million judgment awarded to a family whose daughter developed a life-threatening disease after taking the medicine. The justices on Tuesday let stand a lower court ruling that said Johnson & Johnson should pay the judgment awarded to the family of Samantha Reckis.

from Biotech News

MannKind: Out With The New And In With The Old Game-Plan For Success

MannKind: Out With The New And In With The Old Game-Plan For Success
I/we have no positions in any stocks mentioned, and no plans to initiate any positions within the next 72 hours. I wrote this article myself, and it expresses my own opinions.

from Biotech News

Kenyan man charged for sharing photos of Somalia victims

Kenyan man charged for sharing photos of Somalia victims
A new government report estimates that this year's budget deficit will rise to $544 billion, an increase over prior estimates that can be attributed largely to tax cuts and spending increases passed by Congress... A new government report estimates that this year's budget deficit will rise to $544 billion, an increase over prior estimates that can be attributed largely to tax cuts and spending increases passed by Congress last... The Supreme Court is refusing to revive an Arkansas law that would have banned abortions after the 12th week of pregnancy if doctors can detect a fetal heartbeat.

from Biotech News

Carnage In Biotech: What's Hot And What's Not

Carnage In Biotech: What's Hot And What's Not
I wrote this article myself, and it expresses my own opinions. I am not receiving compensation for it .

from Biotech News

Family Time: Road to recovery: What you need to know about addiction

Family Time: Road to recovery: What you need to know about addiction
Drug and alcohol addiction can destroy careers, tear apart families and ruin lives. With 43,982 total drug-induced deaths each year, addiction continues to be a problem in the United States.

from Biotech News

Celsion Co. (CLSN) Raised to "Buy" at Zacks Investment Research

Celsion Co. (CLSN) Raised to "Buy" at Zacks Investment Research
The firm currently has a $1.50 price objective on the stock. Zacks Investment Research 's price objective would indicate a potential upside of 16.28% from the company's previous close.

from Biotech News

Effort to curb overuse of antibiotics amid cold, flu seasons

Effort to curb overuse of antibiotics amid cold, flu seasons
In this Oct. 8, 2013, file photo, a sign marks the entrance to the federal Centers for Disease Control and Prevention in Atlanta. Guidelines released Monday, Jan. 18, 2016, from CDC and the American College of Physicians, move beyond simple statements that antibiotics don't work for viruses like the common cold or the flu.

from Biotech News

MediciNova's Ibudilast And The Phase IIb Trial Offer Steady Outlook

MediciNova's Ibudilast And The Phase IIb Trial Offer Steady Outlook
I/we have no positions in any stocks mentioned, but may initiate a long position in MNOV over the next 72 hours. I wrote this article myself, and it expresses my own opinions.

from Biotech News

Studienabbrecher sind begehrt

Studienabbrecher sind begehrt
Jährlich brechen in Deutschland bis zu 100.000 Studierende ihr Studium ab. Für Arbeitgeber sind Studienabbrecher sehr attraktiv. Kammern und Bundesbildungsministerium bieten spezielle Programme an, um sie gezielt an Betriebe zu vermitteln. Test.de, das Onlineportal der Stiftung Warentest, erklärt, w...

from bionity.com News | Ein Übersichtsbeitrag über Goldankauf in Berlin, Germany.

Merck & Co vs. Merck KGaA: US-Konzern mit neuer Klage im Namensstreit

Merck & Co vs. Merck KGaA: US-Konzern mit neuer Klage im Namensstreit
(dpa) Neue Runde im langjährigen Namensstreit: Der US-Pharma- und Chemieriese Merck & Co hat den deutschen Konkurrenten Merck KGaA in den USA wegen missbräuchlicher Namensnutzung verklagt. Die Amerikaner wollen verhindern, dass der Darmstädter Konzern in den USA die Marke Merck vertritt und fordern ...

from bionity.com News | Ein Übersichtsbeitrag über Goldankauf in Berlin, Germany.

Zacks Investment Research Downgrades Bayer AG (BAYRY) to Hold

Zacks Investment Research Downgrades Bayer AG (BAYRY) to Hold
According to Zacks, "Bayer's revenues during the third quarter of 2015 were boosted by its newly launched pharmaceutical products. These products are expected to continue their strong run in the upcoming quarters as well.

from Biotech News

Jamaica advises women to delay pregnancy due to Zika virus

Jamaica advises women to delay pregnancy due to Zika virus
This 2006 photo provided by the Centers for Disease Control and Prevention shows a female Aedes aegypti mosquito in the process of acquiring a blood meal from a human host. On Friday, Jan. 15, 2016, U.S. health officials are telling pregnant women to avoid travel to Latin America and Caribbean countries with outbreaks of a tropical illness linked to birth defects.

from Biotech News

Biotech investor: 'None of us were as smart as we thought we were'

Biotech investor: 'None of us were as smart as we thought we were'
It wasn't that long ago that investors couldn't get enough of biotechnology stocks. Now it seems as if they can't get out of the sector fast enough.

from Biotech News

Shire PLC (SHP) Lifted to Outperform at BNP Paribas

Shire PLC (SHP) Lifted to Outperform at BNP Paribas
The brokerage currently has a GBX 5,700 target price on the biopharmaceutical company's stock. BNP Paribas' price objective points to a potential upside of 36.20% from the company's previous close.

from Biotech News

Landscape Shifting for M&A in 2016

Landscape Shifting for M&A in 2016
Low borrowing costs, market stability founded on a strengthening U.S. economy and a gaping tax loophole spurred a record year for mergers and acquisitions in 2015. Those same factors - in reverse - could derail a repeat performance in 2016.

from Biotech News

Johnson & Johnson (JNJ) Receives "AAA" Credit Rating

Johnson & Johnson (JNJ) Receives "AAA" Credit Rating
Johnson & Johnson has been given an "AAA" credit rating by analysts at Morningstar . The investment research firm's "AAA" rating indicates that the company is an extremely-low default risk.

from Biotech News

Zacks Investment Research Upgrades QLT Inc. (QLTI) to "Buy"

Zacks Investment Research Upgrades QLT Inc. (QLTI) to "Buy"
The firm presently has a $2.75 price objective on the stock. Zacks Investment Research 's target price suggests a potential upside of 13.64% from the stock's current price.

from Biotech News

Celgene Co. (CELG) Receives New Coverage from Analysts at Standpoint Research

Celgene Co. (CELG) Receives New Coverage from Analysts at Standpoint Research
The firm set a "buy" rating and a $130.00 price target on the biopharmaceutical company's stock. Standpoint Research's price target points to a potential upside of 26.14% from the stock's previous close.

from Biotech News

Hirntod nach Medikamententest in Frankreich

Hirntod nach Medikamententest in Frankreich
(dpa) Nach heftigen Nebenwirkungen bei einem Medikamententest in Frankreich liegt ein Versuchsteilnehmer hirntot im Krankenhaus. Vier weitere Probanden leiden unter neurologischen Beschwerden, die Ärzte fürchten bei einigen von ihnen bleibende Schäden. «Ihre Not hat mich erschüttert», sagte Gesundhe...

from bionity.com News | Ein Übersichtsbeitrag über Goldankauf in Berlin, Germany.

Novartis announces FDA approval of Cosentyx for treatment of adult patients with AS and PsA

Novartis announces FDA approval of Cosentyx for treatment of adult patients with AS and PsA
Novartis announced today that the US Food and Drug Administration has approved Cosentyx for two new indications - the treatment of adult patients with active ankylosing spondylitis and active psoriatic arthritis . AS and PsA are both life-long, painful and debilitating inflammatory diseases that affect the joints and/or spine.

from Biotech News

Novo Nordisk A/S (NVO) Receives Sell Rating from Zacks Investment Research

Novo Nordisk A/S (NVO) Receives Sell Rating from Zacks Investment Research
's stock had its "sell" rating reissued by Zacks Investment Research in a research report issued to clients and investors on Sunday, MarketBeat.Com reports. According to Zacks, "Novo Nordisk's third-quarter 2015 results were strong with revenues increased on the back of robust performance from Victoza and Levemir as well as significant contributions from Tresiba and Saxenda.

from Biotech News

Pfizer Inc. (PFE) Sees Large Increase in Short Interest

Pfizer Inc. (PFE) Sees Large Increase in Short Interest
Pfizer Inc. saw a large growth in short interest in the month of December. As of December 31st, there was short interest totalling 123,454,015 shares, a growth of 44.1% from the December 15th total of 85,657,779 shares, MarketBeat Ratings reports.

from Biotech News

Baby born in Hawaii with brain damage confirmed to have Zika infection

Baby born in Hawaii with brain damage confirmed to have Zika infection
REUTERS: A baby born with brain damage at a hospital in Oahu, Hawaii, was infected by the Zika virus, U.S. health officials confirmed on Saturday, apparently the first case of the mosquito-borne virus in a birth on U.S. soil. The mother became ill with the Zika virus while living in Brazil in May 2015 and the baby was likely infected in the womb, Hawaiian state health officials and the U.S. Centers for Disease Control and Prevention said.

from Biotech News

Haiti: Six years after quake, UN cites progress but warns of 'deteriorating' situation

Haiti: Six years after quake, UN cites progress but warns of 'deteriorating' situation
New York, Jan 16 :Six years after the devastating earthquake that killed more than 200,000 people and left at least 1.5 million homeless, the United Nations is underlining that humanitarian action has achieved significant results, but that the situation has been deteriorating since June. Despite the progress achieved to date, there are still nearly 60,000 people living in IDP [internally displaced persons] camps in vulnerable situations and in need of humanitarian assistance and durable solutions, said Enzo di Taranto, Head of the United Nations Office for the Coordination of Humanitarian Affairs in Haiti.

from Biotech News

MannKind Co. (MNKD) Upgraded to "Buy" at Zacks Investment Research

MannKind Co. (MNKD) Upgraded to "Buy" at Zacks Investment Research
The brokerage presently has a $1.00 target price on the biopharmaceutical company's stock. Zacks Investment Research 's price objective indicates a potential upside of 7.71% from the company's current price.

from Biotech News

What Pharma/Biotech Investors Need To Know About Adaptive Trials

What Pharma/Biotech Investors Need To Know About Adaptive Trials
The FDA allows for adaptive drug trials during which key protocols may be altered during the course of the trial depending on interim results. Investors concerned with pharmaceutical or biotech drug development, from early to late stages, need to be aware of the benefits and risks of adaptive trials because their use and interpretation can impact corporate valuations.

from Biotech News

Sinovac Biotech Ltd. (SVA) Sees Significant Increase in Short Interest

Sinovac Biotech Ltd. (SVA) Sees Significant Increase in Short Interest
Sinovac Biotech Ltd. was the target of a significant growth in short interest in the month of December. As of December 31st, there was short interest totalling 1,297,916 shares, a growth of 34.1% from the December 15th total of 967,984 shares, Market Beat.com reports.

from Biotech News

Major drugmakers push back in US price debate

Major drugmakers push back in US price debate
With a backlash brewing over the price of medicines in the United States, drugmakers are pushing back with a new message: Most people don't pay retail. Pharmaceutical tablets and capsules in foil strips are arranged on a table in this picture illustration taken in Ljubljana September 18, 2013.

from Biotech News

Pregnant women told to avoid countries with Zika outbreaks

Pregnant women told to avoid countries with Zika outbreaks
This 2006 photo provided by the Centers for Disease Control and Prevention shows a female Aedes aegypti mosquito in the process of acquiring a blood meal from a human host. On Friday, Jan. 15, 2016, U.S. health officials are telling pregnant women to avoid travel to Latin America and Caribbean countries with outbreaks of a tropical illness linked to birth defects.

from Biotech News

Shark Tank funds fewer women than men, with less money

Shark Tank funds fewer women than men, with less money
When Ann Crady Weiss pitched her first start up - a social network known as Maya's Mom that would allow mothers to seek advice and share their experiences - male investors weren't exactly enamored with the idea. "There were many investors I spoke to who said moms don't have time for social networks," Weiss told Mashable.

from Biotech News

Pregnant women told to avoid countries with Zika outbreaks

Pregnant women told to avoid countries with Zika outbreaks
This 2006 photo provided by the Centers for Disease Control and Prevention shows a female Aedes aegypti mosquito in the process of acquiring a blood meal from a human host. On Friday, Jan. 15, 2016, U.S. health officials are telling pregnant women to avoid travel to Latin America and Caribbean countries with outbreaks of a tropical illness linked to birth defects.

from Biotech News

These 6 Things Need To Happen Before Gilead Shares Go Higher

These 6 Things Need To Happen Before Gilead Shares Go Higher
I wrote this article myself, and it expresses my own opinions. I am not receiving compensation for it .

from Biotech News

Merck pays $830 M to settle class-action case over Vioxx

Merck pays $830 M to settle class-action case over Vioxx
Merck will pay $830 million to resolve a federal class-action lawsuit involving shareholders and the painkiller Vioxx, which the drugmaker pulled from the market years ago over safety concerns. Merck said Friday that the case involved people who purchased its securities between 1999 and 2004.

from Biotech News

10 biotech stocks to buy at 'silly' cheap prices

10 biotech stocks to buy at 'silly' cheap prices
If you watched biotechnology stocks rally for the past few years without enjoying the ride, now's the time to make up for lost ground. The sector has been hammered, down to valuations not seen in years, but for reasons that don't add up.

from Biotech News

Raymond James Trust Buys $13,314,000 in Merck & Co., Inc. (MRK) Shares